ALLN
-
ALLN
structure -
-
CAS No:
110044-82-1
-
Formula:
C20H37N3O4
-
Chemical Name:
ALLN
-
Synonyms:
L-Leucinamide,N-acetyl-L-leucyl-N-[(1S)-1-formylpentyl]-;L-Leucinamide,N-acetyl-L-leucyl-N-(1-formylpentyl)-,(S)-;N-Acetyl-L-leucyl-N-[(1S)-1-formylpentyl]-L-leucinamide;Calpain inhibitor I;MG 101;CI-1 (peptide);ALLN;N-Acetyl-L-leucinyl-L-leucinyl-L-norleucinal;ALLnL;Calp I;ALLNal
- Categories:
-
CAS No:
Description
MG-101 is a potent inhibitor of cysteine proteases which inhibits calpain I, calpain II, cathepsin B and cathepsin L with Kis of 190, 220, 150 and 500 pM, respectively.
Acetylleucyl-leucyl-norleucinal is a tripeptide composed of N-acetylleucyl, leucyl and norleucinal residues joined in sequence. It has a role as a cysteine protease inhibitor. It is a tripeptide and an aldehyde.
Characteristics
104
3.37
white powder
1.0±0.1 g/cm3
632.2±50.0 °C at 760 mmHg
192.9±30.3 °C
1.474
soluble in dimethyl sulfoxide, ethanol, methanol. Insoluble in water, and aqueous buffers.DMSO: soluble
−20°C
Drug Information
Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. (See all compounds classified as Cysteine Proteinase Inhibitors.)
Ac-Leu-Leu-Nle-al
ALLN Use and Manufacturing
Calpain inhibitor I reversibly blocks the calcium-dependent neutral cysteine protease calpain I. Calpains have been implicated in various cellular processes, including cell proliferation, apoptosis, and cell differentiation.
Computed Properties
Molecular Weight:383.5
XLogP3:3
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:13
Exact Mass:383.27840667
Monoisotopic Mass:383.27840667
Topological Polar Surface Area:104
Heavy Atom Count:27
Complexity:492
Defined Atom Stereocenter Count:3
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of ALLN
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
US
6 YRS
Business licensed Certified factoryManufactory Supplier of Coenzymes,Inhibito,Enzymes,Zymogens,Substrates
Latest News on ALLN
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
Dabrafenib
1195765-45-7
-
BOC-VAL-VAL-OH
69209-73-0
-
BMS 303141
943962-47-8
-
(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide Formula
60117-17-1
-
(2S)-2-acetamido-6-amino-N-[(2S)-2-amino-3-methylbutanoyl]-N-propylhexanamide Formula
57899-96-4
-
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea Formula
26130-02-9
-
L-Tyrosyl-L-phenylalanine Structure
17355-11-2
-
C-REACTIVE PROTEIN FRAGMENT 77-82 Structure
130349-01-8
-
What is Sildenafil
139755-83-2
-
What is Dacomitinib
1110813-31-4